tiprankstipranks
Trending News
More News >
Singapore Exchange Ltd (SG:S68)
SGX:S68

Singapore Exchange (S68) AI Stock Analysis

Compare
147 Followers

Top Page

SG:S68

Singapore Exchange

(SGX:S68)

Select Model
Select Model
Select Model
Outperform 75 (OpenAI - 5.2)
Rating:75Outperform
Price Target:
S$20.00
â–˛(9.89% Upside)
Action:ReiteratedDate:02/09/26
The score is driven primarily by strong financial performance and a constructive earnings update with reiterated growth targets and committed dividend increases. Offsetting factors are a relatively high P/E and a mostly neutral technical picture with only modest momentum.
Positive Factors
High profitability & margins
SGX's exchange business generates structurally high margins driven by fee-based trading, clearing and data services. Sustained gross margins (>70%) and ~47% net margin indicate pricing power and low incremental costs, enabling durable cash generation and reinvestment capacity over the next 2–6 months.
Diversified multi-asset revenue growth
Revenue growth is broad-based: equities-cash, FX, FICC, commodities and derivatives all contributed. Diversification across asset classes and recurring clearing/data/connectivity fees reduces reliance on any single market cycle and supports management's 6–8% medium-term organic growth target.
Strong cash generation & conservative balance sheet
Robust FCF expansion (+15.8%) combined with conservative leverage gives SGX flexibility to fund dividends, invest in platform upgrades and pursue strategic initiatives. Strong cash conversion underpins the committed dividend lift and provides resilience against episodic revenue swings.
Negative Factors
Treasury income decline
Treasury income is sensitive to interest-rate conditions and collateral currency mix; its decline reduced reported revenue growth and pressured equity derivatives revenue despite stable volumes. This income line can introduce volatility to reported results and compress near-term revenue and margins if rates remain unfavorable.
Execution/timing risk on strategic initiatives
Initiatives such as the Global Listing Board, China secondary-listing pathway and regulated crypto perpetuals carry meaningful upside but require regulatory, issuer and client adoption. Delays or slower take-up would defer expected revenues and may increase near-term investment without immediate returns, pressuring medium-term targets.
Impairment and rising investment-driven costs
The $15m Scientific Beta impairment signals integration or demand shortfalls for that product line. Concurrently, rising staff and professional fees to build new capabilities raise operating expense. If investments take longer to scale, margin expansion and ROE could be constrained despite revenue growth.

Singapore Exchange (S68) vs. iShares MSCI Singapore ETF (EWS)

Singapore Exchange Business Overview & Revenue Model

Company DescriptionSingapore Exchange Limited, together with its subsidiaries, operates as an integrated securities and derivatives exchange, and related clearing houses in Singapore. It operates through Fixed Income, Currencies, and Commodities; Equities; and Data, Connectivity, and Indices segments. The Fixed Income, Currencies, and Commodities segment offers fixed income issuer, trading and clearing, and collateral management services. The Equities segment provides issuer, securities trading and clearing, securities settlement and depository management, derivatives trading and clearing, and collateral management services. The Data, Connectivity, and Indices segment offers market data, connectivity, and indices services. It also provides counterparty guarantee, and depository and related services for securities and derivatives transactions; bond trading services; front-line regulatory functions; computer and software maintenance; operates an electronic foreign exchange trading platform; and management consultancy services for index activities. In addition, the company offers membership and management services to related corporations; distributes bulk freight market indices and information; and operates an electricity market, as well as provides administration services for index calculation, risk analyses, and financial research. It has an agreement in relation to a global partnership to grow New Zealand's Exchange's dairy derivatives market together. Singapore Exchange Limited was incorporated in 1999 and is headquartered in Singapore.
How the Company Makes MoneySingapore Exchange generates revenue through various key streams, primarily from transaction fees, listing fees, and clearing and settlement services. Transaction fees are charged on trades executed on the exchange, contributing significantly to its revenue. Listing fees are collected from companies that choose to list their securities on SGX, providing a steady income source. Additionally, SGX earns revenue from its clearing services, which involve the management and settlement of trades to reduce counterparty risk. The exchange also benefits from data services, offering market data and analytics to investors and institutions for a fee. Strategic partnerships with financial institutions and technology firms enhance SGX's offerings and broaden its market reach, further contributing to its earnings.

Singapore Exchange Earnings Call Summary

Earnings Call Date:Feb 04, 2026
(Q2-2026)
|
% Change Since: |
Next Earnings Date:Jul 30, 2026
Earnings Call Sentiment Positive
The call conveyed broad-based, multi-asset growth with record half-year revenue and earnings, margin expansion, strong FX, equities and commodities momentum, a solid balance sheet and committed dividend increases. Headwinds were limited to a decline in treasury income, a $15m impairment at Scientific Beta, modest cost increases from investments, and execution/timing risks for some new initiatives. Overall, positives around diversified revenue growth and strategic initiatives materially outweigh the contained negatives.
Q2-2026 Updates
Positive Updates
Record Half-Year Revenue and Earnings
Group net revenue rose 7.6% to $695 million and adjusted group NPAT increased 11.6% to $357 million, delivering the highest half-year revenue and earnings for SGX.
Strong Underlying Revenue Growth (Ex-Treasury Income)
Net revenue excluding treasury income grew 10% year-on-year and 8% half-on-half, supporting management's medium-term organic growth ambition of 6%–8% CAGR (ex-TI).
Margin Expansion with Controlled Expense Growth
Adjusted expenses increased a modest 3.8% while adjusted operating profit margin and adjusted NPAT margin improved by 1.4 and 1.8 percentage points respectively, reflecting revenue leverage and cost discipline.
Equities-Cash Momentum and Market Liquidity
Equities-cash revenue grew 16% (up $31 million); Stock exchange SDAV rose 20% to SGD 1.51 billion (highest in 5 years). STI delivered a 23% one-year return and small- & mid-cap SDAV surged >2x, contributing nearly half of overall SDAV growth.
FX Franchise Significant Growth
SGX FX net revenue increased 8% with record average daily value of USD 180 billion; ADV rose 32% YoY and the OTC FX business has CAGR of 39% since inception, underpinning a material future EBITDA contribution.
FICC and Commodities Strength
FICC revenue grew $20 million or 12% (26% of total revenue). Total commodities volume rose 24% with iron ore delivering record half-year volume and broad growth across dairy, petrochemical, freight and rubber contracts.
Derivatives Resilience and Growth
Overall derivatives DAV grew 8% YoY from a high base; highest half-year DDAV of 1.35 million contracts and FX & rates derivatives DDAV grew 18% YoY. Equity derivatives volume remained comparable at 91 million contracts.
Platform, Data and Connectivity Upside
Platform & other revenue increased 7% ($8 million) driven by higher colocation sales and data/connectivity repricing; ongoing market/data platform modernization expected to expand product and data offerings.
Strong Balance Sheet and Capital Return
Moody's reaffirmed AA2 rating; leverage ratio improved to 0.8x. Interim dividend set at $0.11 per share (H1 total $0.2175), over 20% YoY growth, with a committed incremental $0.025 per quarter through FY '28.
Market Development and Strategic Initiatives
IPO pipeline expanded (>30 companies, 18 of prior 30 listed), nearly SGD 3 billion raised in H1 IPOs; strategic initiatives include Global Listing Board with NASDAQ, a China secondary-listing pathway, launch of regulated crypto perpetual futures, 20-year JGB futures and T+1 night trading for rubber.
Negative Updates
Decline in Treasury Income
Treasury income declined due to the global rate environment and collateral currency mix, reducing total net revenue growth (total net revenue up 7.6% vs. net revenue ex-TI up 10%), and contributing to pressure on equity derivatives revenue.
Equity Derivatives Revenue Pressure
Equity derivatives revenue fell $10 million or 6%, largely attributed to lower treasury income despite volumes remaining comparable (91 million contracts).
Impairment for Scientific Beta
A $15 million impairment was recorded due to lower-than-expected performance at Scientific Beta, reflecting integration/market-demand challenges for that business line.
One-Off Cash Items and Redeployment Expectations
Proceeds from sale of 7RIDGE (trading technologies) produced a notable cash inflow (~$420 million reported in questions). Management intends to use proceeds partly to reduce debt, but one-offs temper the sustainability of cash from operations.
Rising Costs from Strategic Investments
Staff costs rose 2.6% and other expenses increased (about $5 million) related to professional fees and FSDF grants; management expects planned investments to skew to H2, keeping full-year expense guide unchanged but increasing near-term investment-driven spend.
Execution and Timing Risks for New Initiatives
While GLB, China secondary listing pathway and crypto/perpetual futures show promise, timelines and adoption remain uncertain (GLB expected mid-year but issuance timing and scale are not guaranteed), and broader institutional onboarding for new products is still required.
Company Guidance
Management reiterated unchanged FY‑26 expense and CapEx guidance and confidence in its medium‑term targets, including a 6–8% CAGR in organic top‑line growth (excluding treasury income) and a committed dividend lift of S$0.025 each quarter through end‑FY28 (interim dividend S$0.11; H1 dividend S$0.2175, >20% YoY); H1 results backing this guidance included group net revenue up 7.6% to $695m (net revenue ex treasury income +10% YoY, +8% half‑on‑half; total net revenue ~+8%), adjusted NPAT +11.6% to $357m, adjusted expenses +3.8%, adjusted operating profit margin +1.4ppt and adjusted NPAT margin +1.8ppt, and a leverage ratio of 0.8x with Moody’s AA2 rating; segment metrics cited to support outlook included equities‑cash revenue +16% (SDAV +20% to SGD1.51bn; small/mid‑cap SDAV >2x and ~50% of SDAV growth; ETFs/SDRs >10% of SDAV growth), overall derivatives DAV +8% (equity derivatives revenue -6% to -$10m but volumes stable at 91m contracts), FICC revenue +$20m/+12% (26% of group revenue) with commodities volumes +24% (iron ore record), SGX FX net revenue +8% with record ADV of USD180bn (c. +32% YoY; ~39% CAGR since inception) and a target for SGX FX to deliver mid‑ to high‑single‑digit EBITDA contribution.

Singapore Exchange Financial Statement Overview

Summary
Strong overall fundamentals: high profitability (gross margin >70%, net margin ~47%), solid cash generation (FCF +15.8%), and conservative leverage (debt-to-equity 0.31). Slightly rising debt is a manageable watch item.
Income Statement
85
Very Positive
The company demonstrates strong profitability with a consistent gross profit margin above 70% and a net profit margin around 47%. Revenue growth is steady, with a 3.7% increase in the latest period. EBIT and EBITDA margins are robust, indicating efficient operations. Overall, the income statement reflects a healthy financial performance with stable growth.
Balance Sheet
78
Positive
The balance sheet shows a moderate debt-to-equity ratio of 0.31, indicating a conservative leverage approach. Return on equity is strong at approximately 29.5%, reflecting effective use of shareholder funds. The equity ratio is healthy, suggesting a solid capital structure. However, the slight increase in debt over time warrants monitoring.
Cash Flow
82
Very Positive
Cash flow analysis reveals a significant growth in free cash flow by 15.8%, indicating strong cash generation capabilities. The operating cash flow to net income ratio is healthy, supporting the company's ability to convert earnings into cash. The free cash flow to net income ratio is high, reflecting efficient cash management. Overall, cash flow metrics are strong, supporting the company's financial stability.
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue1.42B1.37B1.23B1.19B1.10B1.06B
Gross Profit993.11M1.02B884.11M1.02B933.17M898.49M
EBITDA902.50M888.14M815.18M753.33M641.23M632.36M
Net Income650.70M647.98M597.91M570.89M451.40M445.41M
Balance Sheet
Total Assets4.16B4.14B3.98B3.78B3.86B3.02B
Cash, Cash Equivalents and Short-Term Investments2.05B1.51B1.13B1.07B1.09B1.10B
Total Debt722.54M688.10M728.01M727.22M788.87M539.18M
Total Liabilities1.87B1.94B2.02B2.08B2.31B1.63B
Stockholders Equity2.29B2.20B1.96B1.70B1.54B1.38B
Cash Flow
Free Cash Flow765.47M773.56M551.23M417.38M562.07M524.51M
Operating Cash Flow836.52M841.67M615.80M470.66M606.22M569.80M
Investing Cash Flow179.53M-265.90M-137.90M-5.79M-555.82M-209.21M
Financing Cash Flow-464.60M-449.36M-459.69M-428.43M-106.36M-207.79M

Singapore Exchange Technical Analysis

Technical Analysis Sentiment
Positive
Last Price18.20
Price Trends
50DMA
17.51
Positive
100DMA
17.18
Positive
200DMA
16.22
Positive
Market Momentum
MACD
0.16
Positive
RSI
56.70
Neutral
STOCH
26.65
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:S68, the sentiment is Positive. The current price of 18.2 is above the 20-day moving average (MA) of 17.94, above the 50-day MA of 17.51, and above the 200-day MA of 16.22, indicating a bullish trend. The MACD of 0.16 indicates Positive momentum. The RSI at 56.70 is Neutral, neither overbought nor oversold. The STOCH value of 26.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:S68.

Singapore Exchange Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$19.49B29.9230.82%2.27%11.28%8.34%
73
Outperform
$162.33B14.8317.10%5.06%2.67%6.32%
71
Outperform
S$96.31B13.1512.87%4.71%0.69%-0.06%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
66
Neutral
S$3.06B12.4110.50%4.63%7.87%-4.03%
64
Neutral
S$61.10B13.3912.80%6.49%-0.76%4.96%
64
Neutral
S$1.08B3.248.61%3.76%-9.47%131.72%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:S68
Singapore Exchange
18.06
5.18
40.21%
SG:D05
DBS Group Holdings
55.63
12.71
29.63%
SG:O39
OCBC
20.93
4.75
29.36%
SG:U11
UOB
36.30
0.47
1.31%
SG:U10
UOB-Kay Hian Holdings Limited
3.22
1.55
92.58%
SG:YF8
Yangzijiang Financial Holding Ltd.
0.29
0.01
5.07%

Singapore Exchange Corporate Events

SGX RegCo Moves to Broaden Use of Broker Custody Accounts to Modernise Market Infrastructure
Jan 30, 2026

Singapore Exchange Regulation is proposing rule amendments to encourage broader use of broker custody accounts for SGX-listed securities, aligning Singapore’s post-trade custody framework with global market practices. By shifting more investors towards an omnibus broker custody model, SGX RegCo aims to allow retail investors to consolidate local and foreign portfolios with a single broker and access value-added services such as fractional trading, robo-investing and portfolio management, while making it easier for internationally active asset managers—already familiar with omnibus structures—to participate in Singapore’s market. The regulator emphasises that as the infrastructure is modernised, the custody framework will remain robust, with stronger and more consistent operational standards across intermediaries intended to safeguard investors and support wider adoption of the broker custody model, thereby bolstering Singapore’s competitiveness as a trading and investment centre.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$21.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

SGX boosts ASEAN income access with listing of UOBAM Ping An dividend ETF
Jan 29, 2026

Singapore Exchange’s securities platform has added the UOBAM Ping An FTSE ASEAN Dividend Index ETF to its roster, broadening income-focused access to Southeast Asian equities for investors. The ETF, managed by UOB Asset Management, tracks the FTSE ASEAN ex REITs Target Dividend Index, comprising 57 large- and mid-cap companies across Singapore, Indonesia, Thailand, Malaysia and the Philippines, and is designed to deliver higher dividend yields and defensive characteristics relative to the broader ASEAN market, with trading available in both Singapore and US dollars. SGX executives framed the listing as a further step in leveraging Singapore’s role as a regional capital hub by offering a simple, cost-efficient vehicle into high-quality, dividend-paying ASEAN companies, while UOBAM highlighted the region’s structural growth, favourable demographics and strong fundamentals as underpinning investor demand for yield and stability amid volatile markets. With this launch, SGX’s ETF shelf grows to 52 listings and more than S$18 billion in assets under management, reinforcing its positioning as a key venue for Asia-centric ETF products and potentially enhancing liquidity and choice for investors seeking diversified regional income strategies.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$21.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

The Assembly Place Lists on SGX Catalist to Drive Regional Co-Living Expansion
Jan 23, 2026

Singapore Exchange’s Catalist board has welcomed the listing of The Assembly Place Holdings Ltd. under the stock code “TAP”, marking a key milestone for the fast-growing community living operator and adding to the more than 200 enterprises on the junior board. The IPO is intended to fund TAP’s next phase of scalable growth, including a target to nearly triple its portfolio to 10,000 keys by 2030, expand vertically into complementary living segments such as workers’ dormitories, and support entry into new Southeast Asian markets starting with a planned Kuala Lumpur development, as SGX highlights rising investor interest in living-space assets amid changing work, urbanisation and travel trends.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$21.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

SGX RegCo Proposes Smaller Board Lot Sizes to Boost Access to Higher-Priced Stocks
Jan 23, 2026

Singapore Exchange Regulation is consulting the public on a proposal to cut standard board lot sizes for higher-priced stocks on SGX’s stock market, aiming to lower the minimum investment outlay and make such securities more affordable for investors. Under the plan, instruments priced above S$10 and up to S$100 would see their board lot size reduced from 100 units to 10, while those priced above S$100 would be cut from 100 units to 1, a move expected to increase accessibility, broaden investor participation—particularly among younger retail investors—and potentially boost trading activity in a segment that already accounts for about 30% of market turnover. SGX RegCo is also proposing to remove the requirement to match minimum bid sizes for Hong Kong dollar, Renminbi and Japanese yen securities and futures to their home markets, following a structural review, with both sets of changes targeted for implementation in mid-2026 subject to market support.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$21.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

AI CX Platform Toku Lists on SGX Catalist to Fuel Global Expansion
Jan 22, 2026

Singapore Exchange’s Catalist board has welcomed the listing of Toku Ltd., an AI-driven customer experience platform, under the stock code “TKU”, with the shares opening at S$0.26. The debut underscores SGX Catalist’s growing appeal to technology and AI-focused enterprises and provides Toku with a capital markets springboard to scale its operations and international presence; SGX executives highlighted Toku’s role in supporting digital transformation across diverse markets, while the company’s CEO framed the listing as a key milestone in its ambition to become a global standard-setter in how businesses connect with customers in complex, multilingual and regulated environments.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$21.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

SGX adds China-focused CSI A500 ETF as cross-border ETF link deepens
Jan 20, 2026

Singapore Exchange has welcomed the listing of the CSOP CSAM CSI A500 Index ETF under the Shenzhen Stock Exchange–SGX ETF Link, giving investors a more convenient route to access China’s A-share market via a broad-based benchmark of 500 large and liquid Chinese companies. The new ETF, managed by CSOP Asset Management, is heavily weighted towards innovation-driven sectors such as technology hardware and advanced manufacturing, and its addition marks the 11th ETF under the China–Singapore ETF Link and the 6th under the SZSE–SGX ETF Link, underscoring deepening capital-market collaboration between Singapore and China. The launch expands SGX’s ETF shelf to 51 products with more than S$18 billion in assets under management and comes amid strong growth in its ETF segment, where total AUM rose 37% and average daily turnover jumped 69% in 2025, reinforcing SGX’s drive to cement its position as a leading gateway to China’s equity growth for global investors.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$21.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

SGX RegCo Unveils Proposed Rules for New Global Listing Board with Nasdaq
Jan 9, 2026

Singapore Exchange Regulation is consulting on detailed listing rules for a new Global Listing Board designed to support streamlined dual listings on SGX and Nasdaq, following a broader equities market review aimed at strengthening Singapore’s position as an international equities hub. The proposed framework would create a harmonised pathway for companies to access capital and liquidity in both North America and Asia using a single set of offering documents and a simplified review process, supported by legislative changes to Singapore’s Securities and Futures Act. Key admission criteria include a minimum market capitalisation of S$2 billion, a requirement that issuers be listed or accepted for listing on the Nasdaq Global Select Market, local governance and compliance touchpoints in Singapore, retail allocation via designated brokerages, and the appointment of an issue manager, collectively signalling tighter standards but potentially higher-quality cross-border listings for investors.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

SGX Ends 2025 With Record Derivatives Volumes and Surging Securities Activity
Jan 9, 2026

SGX Group capped a strong 2025 with robust December trading activity, underscoring sustained momentum in Singapore’s stock and derivatives markets. Securities turnover for December surged 29% year-on-year to S$25.8 billion, driving full-year securities daily average value to its highest level since 2010, while derivatives volumes across equities, FX and commodities hit a record 329 million contracts for the year, reflecting strong institutional demand for risk-management tools. The Straits Times Index delivered standout returns in 2025, outperforming most ASEAN peers, alongside rising retail participation and net institutional buying of small- and mid-cap stocks. Capital-raising activity continued with multiple new Mainboard and Catalist listings, and SGX reinforced its role as a key derivatives hub, with strong growth in MSCI Singapore Index contracts and record volumes and open interest in China A- and H-share futures, consolidating its status as a leading gateway for China exposure.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

SGX Group Announces CRO Transition as Veteran Risk Chief Agnes Koh Steps Down
Jan 6, 2026

Singapore Exchange (SGX Group) announced that long-serving Chief Risk Officer (CRO) Agnes Koh will step down at the end of the current quarter, with Deputy CRO Ivan Han becoming CRO-designate immediately and formally assuming the role on 1 April 2026. Koh, who joined SGX in 2005 and led its risk function through events such as the Global Financial Crisis and the collapse of MF Global, will move into a special advisory role from July, ensuring continuity as Han – a senior executive with experience spanning FX, rates, equities products and regulatory engagement – takes over. The planned succession underscores SGX Group’s emphasis on maintaining strong risk management and operational resilience amid increasingly complex global markets, while preserving institutional knowledge through Koh’s ongoing advisory capacity.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

Concord New Energy secures secondary listing on SGX Mainboard to fuel global renewables push
Jan 6, 2026

Singapore Exchange (SGX) has welcomed Concord New Energy Group Limited to its Mainboard via a secondary listing under the stock code “SEG”, broadening the renewable energy player’s access to international capital. The move marks a strategic milestone in CNE’s global expansion, reinforcing its commitment to stronger corporate governance and deeper engagement with global investors as it supports the transition from fossil fuels to clean energy. For SGX, the listing underscores its ambition to position itself as Asia’s leading multi-asset hub for transition finance, leveraging Singapore’s role at the intersection of artificial intelligence, next-generation energy systems and global capital markets, and offering CNE a broader platform to attract diverse investors, customers and partners for scaling renewable infrastructure.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

SGX RegCo Names Dr Sung Cheng Chih as New Chairman, Succeeding Professor Tan Cheng Han
Dec 31, 2025

Singapore Exchange Regulation (SGX RegCo) has appointed Dr Sung Cheng Chih as its non-executive and independent chairman with effect from 1 January 2026, succeeding Professor Tan Cheng Han, who is stepping down after almost nine years on the board and as the unit’s inaugural chairman. Dr Sung, a former Chief Risk Officer at GIC and co-founder of Avanda Investment Management, brings deep financial markets and risk management experience to SGX RegCo as it moves to implement recommendations from the Equities Market Review Group, while Professor Tan’s tenure is credited with strengthening SGX RegCo’s standing as a trusted independent regulator and advancing governance, board renewal and diversity in Singapore’s capital markets.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

Leong Guan Holdings Limited Debuts on SGX Catalist
Dec 11, 2025

Leong Guan Holdings Limited has been listed on the SGX Catalist, marking a significant milestone for the company. This listing is expected to bolster Leong Guan’s growth by enabling expansion into new export markets, diversification of product offerings, and upgrades to manufacturing facilities with sustainable initiatives. The move also highlights the company’s strategic plans for acquisitions and joint ventures to further scale its operations. SGX’s support underscores its commitment to fostering ambitious businesses in Singapore’s food manufacturing sector.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

SGX Group Reports Strong November Trading Activity
Dec 10, 2025

In November, SGX Group reported strong trading activity in the Singapore stock market, with the Straits Times Index reaching a new high and turnover increasing significantly. The commodities sector saw a year-on-year rise in activity, particularly in iron ore, freight, and petrochemical contracts. The introduction of new Singapore Depository Receipts and increased interest in China and India equities further bolstered SGX’s market position. Taiwan’s market also benefited from AI demand, contributing to the overall robust performance.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

SGX Announces Quarterly Rebalancing of iEdge Singapore Next 50 Indices
Dec 9, 2025

Singapore Exchange Limited (SGX) has announced the quarterly rebalancing results for the iEdge Singapore Next 50 Indices, which will take effect on 22 December 2025. The changes include the addition of Golden Agri-Resources Ltd, Yangzijiang Maritime Development Ltd, and Centurion Accommodation Reit, while Nanofilm Technologies International Ltd, Samudera Shipping Line Ltd, and Aztech Global Ltd have been removed. This rebalancing reflects SGX’s ongoing efforts to maintain a dynamic and representative index, potentially impacting the market positions of the included and excluded companies.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

No Changes to Straits Times Index Constituents in December 2025 Review
Dec 4, 2025

FTSE Russell has announced that there will be no changes to the constituents of the Straits Times Index (STI) following the December 2025 quarterly review. The STI is reviewed quarterly to ensure it accurately represents the investable universe for benchmarking purposes. The reserve list for the STI has been updated, with CapitaLand Ascott Trust, Keppel REIT, NetLink NBN Trust, Sheng Siong Group, and Suntec REIT now included. These changes will take effect on 22 December 2025, with the next review scheduled for March 2026.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

Infinity Development Joins SGX Catalist, Expanding Regional Presence
Dec 3, 2025

Infinity Development Holdings Company Limited has successfully listed on the SGX Catalist under the stock code ‘ZBA’, marking a significant milestone in its growth trajectory. This dual listing, alongside its presence on the Hong Kong Stock Exchange, is expected to bolster its regional presence and capitalize on growing investor interest in Singapore’s capital markets. The move is seen as a strategic step to pursue new growth opportunities and strengthen its position in the industry.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

UltraGreen.ai Debuts on SGX Mainboard, Boosting MedTech Presence
Dec 3, 2025

UltraGreen.ai Limited has successfully listed on the SGX Mainboard, marking a significant milestone in the company’s growth and its role in advancing fluorescence-guided surgery. The listing is expected to enhance UltraGreen.ai’s ability to expand its market reach and accelerate commercial execution, reflecting the growing recognition of fluorescence-guided surgery’s impact on surgical precision. This development also underscores the strength of Singapore’s MedTech sector, which continues to attract innovative healthcare technology companies.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

SGX Orb Awards 2025 Highlights Multi-Generational Financial Insights
Nov 27, 2025

The SGX Orb Awards 2025 celebrated excellence in financial journalism, highlighting diverse and multi-generational perspectives on capital markets. This year’s awards introduced a special category for youth, encouraging innovative ideas on the future of exchanges, with entries evaluated by an independent panel of industry experts. The initiative underscores SGX’s commitment to investor education and fostering dialogue in the financial community.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

SGX Partners with Nasdaq for Global Listing Board
Nov 19, 2025

SGX Group has partnered with Nasdaq to launch a Global Listing Board, enabling companies with a market capitalization of S$2 billion and above to dual list in the U.S. and Singapore. This initiative aims to streamline regulatory processes, reduce costs, and enhance market visibility, thereby fostering growth and innovation in both financial hubs. The collaboration is part of broader efforts to strengthen Singapore’s stock market appeal, supported by initiatives like the Anchor Fund @ 65, which aims to boost equity financing for high-growth enterprises.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

Yangzijiang Maritime Development Ltd. Debuts on SGX Mainboard
Nov 18, 2025

SGX Securities has announced the listing of Yangzijiang Maritime Development Ltd. on its Mainboard under the stock code ‘8YZ’. This listing marks a significant milestone for the company, which aims to capitalize on growth opportunities in the evolving maritime industry, focusing on sustainability and innovation. The listing is seen as a strategic move to enhance the company’s investment focus and create long-term value. It also reflects Singapore’s position as a leading international maritime hub, offering new opportunities for both the company and investors.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

SGX Derivatives Launches Institutional-Grade Crypto Perpetual Futures
Nov 17, 2025

SGX Derivatives is set to launch Bitcoin and Ethereum perpetual futures on November 24, 2025, marking a significant advancement in institutional crypto trading. This initiative aims to bring the discipline and transparency of global financial markets to crypto trading, offering institutional-grade products within a regulated framework. By aligning with the iEdge CoinDesk Crypto Indices, SGX aims to enhance price discovery and provide institutions with the trust and scalability needed to confidently engage in crypto markets, potentially shifting a significant portion of the crypto derivatives market onshore.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

SGX Indices Launches CSI SGX Asia 100 Indices for Broader Asian Market Exposure
Nov 12, 2025

SGX Indices has launched the CSI SGX Asia 100 Indices, enhancing its suite of Asia-focused benchmarks in collaboration with China Securities Index Co., Ltd. This new set of indices provides diversified exposure to the largest companies across major Asian markets, including China, Hong Kong, India, Indonesia, Japan, Singapore, and South Korea. The indices are designed to offer investors a transparent and rules-based framework, facilitating long-term participation in Asia’s growth. This initiative follows the successful introduction of the CSI SGX Emerging Asia Technology Index in 2024, which has shown significant returns, highlighting SGX’s commitment to strengthening Asia-focused benchmarks.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

SGX Group’s October Performance Boosted by Institutional Inflows and Market Connectivity
Nov 11, 2025

SGX Group reported a strong performance in October, driven by institutional inflows and active risk management amid global economic shifts. The securities market saw a 26% year-on-year increase in turnover, with significant contributions from index and small- to mid-cap stocks. The launch of the Indonesia-Singapore Depository Receipt Linkage further deepened ASEAN market connectivity. Additionally, the SGX FTSE China A50 Index Futures experienced a surge in activity due to geopolitical uncertainties, while Taiwan’s equity markets benefited from global AI demand.

The most recent analyst rating on (SG:S68) stock is a Buy with a S$20.00 price target. To see the full list of analyst forecasts on Singapore Exchange stock, see the SG:S68 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 09, 2026